Considering jointly the significant impact of CEA produced by the primary tumor on the occurrence of colorectal cancer, our data found that CSR has significant statistically difference in patients with and without liver metastases (p<0.0001) (Figure 7E). This evidence concerns the gene CEACAM5 and colorectal cancer.